ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
Company to host corporate webcast to share updated data on December 3, 2025 ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Wednesday, December 3, 2025, at 8:00 a.m. EST to provide […]